Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases. read more
Jeffrey Walsh ā Principal Financial Officer at bluebird bio
Executive Bio
Mr. Jeffrey T. Walsh, also known as Jeff, MBA, has been the Chief Financial Officer of bluebird bio, Inc. (alternate name, Genetix Pharmaceuticals Inc.) since March 1, 2016 and served as its Principal Accounting Officer until December 18, 2017. Mr. Walsh served as the Chief Operating Officer of bluebird bio from May 16, 2011 to February 29, 2016 and served as its Treasurer since March 2014. Mr. Walsh served as Principal Financial Officer of bluebird bio, Inc. from June 2013 to November 2014. He served as Secretary at bluebird bio, Inc since March 2013. He has more than 20 years of experience in executive leadership positions with responsibility for finance, business development, commercial and business operations, strategic planning and legal functions with established and emerging public and private life sciences companies. He served as Chief Business Officer of Taligen Therapeutics, Inc. since December 1, 2008 and served as its Treasurer. He served as Executive Vice President and Chief Business Officer of Inotek Pharmaceuticals Corporation. He served as Vice President of Corporate Development and Commercial Planning of Inotek Pharmaceuticals Corporation. Mr. Walsh joined Inotek in March 2004. He started his career at SmithKline Beecham Corporation (now GlaxoSmithKline) in its two-year, corporate management training program. He subsequently worked in SmithKline's US National Accounts group in contract management and as a senior manager in SmithKline's worldwide business development group. He held various senior-level positions in worldwide business development, strategic marketing and corporate finance for PathoGenesis Corporation (now Chiron Corporation) and EXACT Sciences Corporation. He served as Senior Director of Corporate Finance and Business Analytics at PathoGenesis Corporation (now part of Novartis), Vice President of Managed Care and Business Development at Allscripts and Vice President of Business Development and Corporate Planning at EXACT Sciences. He serves as a Director of Alliance for Regenerative Medicine. Mr. Walsh received his M.B.A. from the Kellogg Graduate School of Management at Northwestern University and his B.A. in economics and sociology from Yale University.
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Executive Team Culture Ratings from bluebird bio Employees
BOTTOM
30%
bluebird bio's Executive Team scores in the Bottom 30%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at bluebird bioNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at bluebird biobluebird bio's Executive Team at a Glance
Based on 6 ratings, bluebird bio's employees are less satisfied with their Executive Team and give them a āC-ā or 61/100.
bluebird bio's Executive Team ranks in the Bottom 30% of other companies in Boston and Bottom 30% of other companies on Comparably that also have 51-200 Employees.
×